• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质结构特征可预测对三种溶酶体贮积症的药物伴侣治疗的反应性。

Protein structural features predict responsiveness to pharmacological chaperone treatment for three lysosomal storage disorders.

机构信息

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States of America.

Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, United States of America.

出版信息

PLoS Comput Biol. 2021 Sep 16;17(9):e1009370. doi: 10.1371/journal.pcbi.1009370. eCollection 2021 Sep.

DOI:10.1371/journal.pcbi.1009370
PMID:34529671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8478239/
Abstract

Three-dimensional structures of proteins can provide important clues into the efficacy of personalized treatment. We perform a structural analysis of variants within three inherited lysosomal storage disorders, comparing variants responsive to pharmacological chaperone treatment to those unresponsive to such treatment. We find that predicted ΔΔG of mutation is higher on average for variants unresponsive to treatment, in the case of datasets for both Fabry disease and Pompe disease, in line with previous findings. Using both a single decision tree and an advanced machine learning approach based on the larger Fabry dataset, we correctly predict responsiveness of three Gaucher disease variants, and we provide predictions for untested variants. Many variants are predicted to be responsive to treatment, suggesting that drug-based treatments may be effective for a number of variants in Gaucher disease. In our analysis, we observe dependence on a topological feature reporting on contact arrangements which is likely connected to the order of folding of protein residues, and we provide a potential justification for this observation based on steady-state cellular kinetics.

摘要

蛋白质的三维结构可以为个性化治疗的疗效提供重要线索。我们对三种遗传性溶酶体贮积症中的变体进行了结构分析,比较了对药物伴侣治疗有反应和无反应的变体。我们发现,在法布里病和庞贝病的数据集情况下,对于无反应的治疗变体,预测突变的 ΔΔG 平均更高,这与以前的发现一致。使用单个决策树和基于较大法布里数据集的先进机器学习方法,我们正确预测了三种戈谢病变体的反应性,并对未经测试的变体提供了预测。许多变体被预测对治疗有反应,这表明基于药物的治疗可能对戈谢病的许多变体有效。在我们的分析中,我们观察到依赖于拓扑特征报告关于接触排列的情况,这可能与蛋白质残基折叠的顺序有关,并且我们基于稳态细胞动力学为这一观察结果提供了一个潜在的理由。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/f6a984c0ec53/pcbi.1009370.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/56b627b5089f/pcbi.1009370.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/b77bc29d2583/pcbi.1009370.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/ecfdb6702056/pcbi.1009370.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/4dab85eb49a3/pcbi.1009370.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/f6a984c0ec53/pcbi.1009370.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/56b627b5089f/pcbi.1009370.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/b77bc29d2583/pcbi.1009370.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/ecfdb6702056/pcbi.1009370.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/4dab85eb49a3/pcbi.1009370.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7979/8478239/f6a984c0ec53/pcbi.1009370.g005.jpg

相似文献

1
Protein structural features predict responsiveness to pharmacological chaperone treatment for three lysosomal storage disorders.蛋白质结构特征可预测对三种溶酶体贮积症的药物伴侣治疗的反应性。
PLoS Comput Biol. 2021 Sep 16;17(9):e1009370. doi: 10.1371/journal.pcbi.1009370. eCollection 2021 Sep.
2
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease.体外酶活性测定以检测法布里病和庞贝病中药物伴侣分子的反应性
J Vis Exp. 2017 Dec 20(130):56550. doi: 10.3791/56550.
3
Lysosomal storage disorders: Novel and frequent pathogenic variants in a large cohort of Indian patients of Pompe, Fabry, Gaucher and Hurler disease.溶酶体贮积症:庞贝病、法布雷病、戈谢病和黏多糖贮积症大型印度患者队列中的新的和常见的致病性变异体。
Clin Biochem. 2021 Mar;89:14-37. doi: 10.1016/j.clinbiochem.2020.12.002. Epub 2020 Dec 8.
4
Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases.用于溶酶体贮积症的基于糖模拟物的药理伴侣分子:来自戈谢病、GM1神经节苷脂贮积症和法布里病的经验教训
Chem Commun (Camb). 2016 Apr 25;52(32):5497-515. doi: 10.1039/c6cc01564f.
5
[Enzyme replacement therapy for lysosomal storage disorders].[溶酶体贮积症的酶替代疗法]
Arch Pediatr. 2011 Oct;18(10):1119-23. doi: 10.1016/j.arcped.2011.07.002. Epub 2011 Aug 27.
6
Enzyme replacement for lysosomal diseases.用于溶酶体疾病的酶替代疗法
Annu Rev Med. 2006;57:283-96. doi: 10.1146/annurev.med.57.110104.115650.
7
Treating lysosomal storage disorders: What have we learnt?治疗溶酶体贮积症:我们学到了什么?
J Inherit Metab Dis. 2020 Jan;43(1):125-132. doi: 10.1002/jimd.12131. Epub 2019 Jun 26.
8
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification.药理学伴侣在溶酶体贮积症中的治疗作用:证据回顾与再分类的明智方法。
Biomolecules. 2023 Aug 7;13(8):1227. doi: 10.3390/biom13081227.
9
Chemical chaperones--a new concept in drug research.化学伴侣分子——药物研究中的一个新概念。
Chembiochem. 2003 Apr 4;4(4):260-4. doi: 10.1002/cbic.200390045.
10
Current enzyme replacement therapy for the treatment of lysosomal storage diseases.目前用于治疗溶酶体贮积症的酶替代疗法。
Pediatr Ann. 2009 Aug;38(8):448-55. doi: 10.3928/00904481-20090723-09.

引用本文的文献

1
Bioinformatics-Driven Multi-Factorial Insight into α-Galactosidase Mutations.生物信息学驱动的对α-半乳糖苷酶突变的多因素洞察
Int J Mol Sci. 2025 Jun 17;26(12):5802. doi: 10.3390/ijms26125802.
2
Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer.基于AlphaFold结构的蛋白质稳定性预测对癌症错义变异的评估
Front Genet. 2023 Feb 21;14:1052383. doi: 10.3389/fgene.2023.1052383. eCollection 2023.
3
Circuit topology predicts pathogenicity of missense mutations.电路拓扑结构可预测错义突变的致病性。

本文引用的文献

1
A conserved folding nucleus sculpts the free energy landscape of bacterial and archaeal orthologs from a divergent TIM barrel family.一个保守的折叠核心塑造了来自不同 TIM 桶家族的细菌和古菌直系同源物的自由能景观。
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17). doi: 10.1073/pnas.2019571118.
2
Structural aspects of rod opsin and their implication in genetic diseases.视蛋白的结构方面及其在遗传性疾病中的意义。
Pflugers Arch. 2021 Sep;473(9):1339-1359. doi: 10.1007/s00424-021-02546-x. Epub 2021 Mar 16.
3
Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions.
Proteins. 2022 Sep;90(9):1634-1644. doi: 10.1002/prot.26342. Epub 2022 Apr 23.
法布里病:分子基础、病理生理学、诊断及潜在治疗方向
Biomolecules. 2021 Feb 12;11(2):271. doi: 10.3390/biom11020271.
4
ADDRESS: A Database of Disease-associated Human Variants Incorporating Protein Structure and Folding Stabilities.地址:一个包含疾病相关人类变异体、蛋白质结构和折叠稳定性的数据库。
J Mol Biol. 2021 May 28;433(11):166840. doi: 10.1016/j.jmb.2021.166840. Epub 2021 Feb 2.
5
The rapidly evolving view of lysosomal storage diseases.溶酶体贮积症的快速演变观点。
EMBO Mol Med. 2021 Feb 5;13(2):e12836. doi: 10.15252/emmm.202012836. Epub 2021 Jan 18.
6
Identification of pathogenic missense mutations using protein stability predictors.利用蛋白质稳定性预测器鉴定致病性错义突变。
Sci Rep. 2020 Sep 21;10(1):15387. doi: 10.1038/s41598-020-72404-w.
7
Precision Medicine for Lysosomal Disorders.精准医学治疗溶酶体贮积症
Biomolecules. 2020 Jul 26;10(8):1110. doi: 10.3390/biom10081110.
8
Second-Generation Pharmacological Chaperones: Beyond Inhibitors.第二代药理学伴侣:超越抑制剂。
Molecules. 2020 Jul 9;25(14):3145. doi: 10.3390/molecules25143145.
9
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations.药理学伴侣:一种治疗由不稳定错义突变引起的疾病的方法。
Int J Mol Sci. 2020 Jan 13;21(2):489. doi: 10.3390/ijms21020489.
10
DeepMSA: constructing deep multiple sequence alignment to improve contact prediction and fold-recognition for distant-homology proteins.DeepMSA:构建深度多重序列比对以改进远距离同源蛋白质的接触预测和折叠识别。
Bioinformatics. 2020 Apr 1;36(7):2105-2112. doi: 10.1093/bioinformatics/btz863.